Life Technologies Foundation

2010 Funding Opportunities

The Life Technologies Foundation™ is dedicated to recognizing the power of each scientist’s contribution to improving the human condition.

By teaming with researchers across countries and cultures, we strive to demystify the world of life science, empower today’s children to become tomorrow’s scientific leaders and deepen society’s appreciation of science and its profound impact on our lives. Local organizations within communities where Life Technologies has a presence are welcome to apply. "Local" is defined as within a 50 mile radius of a Life Technologies owned or leased facility within the United States. Potential applicants should view the PDF application and guideline forms to the right-hand side of this page.

Life Technologies Foundation Logo

Life Technologies Foundation

7305 Executive Way
Frederick, Maryland 21704
U.S.
foundation@lifetech.com

  • Life Technology Foundation Group Photo
  • Life Technology Foundation Lab Photo
  • Life Technology Foundation Event Photo

News

  • TGen Study

    LifeTechnologies Corporation announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies. The goal of this first-of-its-kind research collaboration is to demonstrate whether genomic sequencing of cancer tissue can provide clues for treatment strategies for these individuals.

    Read All Close
  • SMS Technology

    Life Technologies Corporation announced early stage results from its single molecule sequencing (SMS) technology. The technology promises to combine virtually unlimited continuous long read lengths with unmatched accuracy to deliver targeted genomic sequence data in a matter of hours, paving the way for sequencing to become a commonplace tool in research laboratories and clinical settings worldwide.

    Read All Close
  • SOLiD PI ANNOUNCED

    Life Technologies Corporation today announced plans for the Applied Biosystems SOLiD(TM) PI System, a new highly accurate, flexible and easy-to-use genomic analysis platform that will bring next-generation sequencing within the grasp of all life science research laboratories worldwide. Early customer adoption of the SOLiD PI System is expected to begin in the second half of 2010.

    Read All Close

Life (Common Stock)